These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1179 related items for PubMed ID: 19427095

  • 1. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N, Resche-Rigon M, Morin C, Ville Y, Rozenberg P.
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [Abstract] [Full Text] [Related]

  • 2. Outcomes for subsequent pregnancy in women who have undergone misoprostol mid-trimester termination of pregnancy.
    Mirmilstein V, Rowlands S, King JF.
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):195-7. PubMed ID: 19432610
    [Abstract] [Full Text] [Related]

  • 3. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study.
    Moreau C, Kaminski M, Ancel PY, Bouyer J, Escande B, Thiriez G, Boulot P, Fresson J, Arnaud C, Subtil D, Marpeau L, Rozé JC, Maillard F, Larroque B, EPIPAGE Group.
    BJOG; 2005 Apr; 112(4):430-7. PubMed ID: 15777440
    [Abstract] [Full Text] [Related]

  • 4. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT, Papatsonis DN, Heydanus R.
    Ned Tijdschr Geneeskd; 2007 Apr 07; 151(14):815-20. PubMed ID: 17469323
    [Abstract] [Full Text] [Related]

  • 5. Does induced abortion increase the risk of preterm birth? Results from a case-control study.
    Parazzini F, Ricci E, Chiaffarino F, Cipriani S, Tozzi L, Fedele L.
    Gynecol Obstet Invest; 2010 Apr 07; 69(1):40-5. PubMed ID: 19887819
    [Abstract] [Full Text] [Related]

  • 6. Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience.
    Boza AV, de León RG, Castillo LS, Mariño DR, Mitchell EM.
    Reprod Health Matters; 2008 May 07; 16(31 Suppl):189-95. PubMed ID: 18772100
    [Abstract] [Full Text] [Related]

  • 7. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL, Gallego FG, Llorente MP, Bermúdez SB, Sala ES, González LV, Texidó CS.
    Contraception; 2008 Jul 07; 78(1):52-60. PubMed ID: 18555818
    [Abstract] [Full Text] [Related]

  • 8. Modelling sequence of prior pregnancies on subsequent risk of very preterm birth.
    Watson LF, Rayner JA, King J, Jolley D, Forster D, Lumley J.
    Paediatr Perinat Epidemiol; 2010 Sep 07; 24(5):416-23. PubMed ID: 20670222
    [Abstract] [Full Text] [Related]

  • 9. Previous pregnancy loss: risks related to severity of preterm delivery.
    Buchmayer SM, Sparén P, Cnattingius S.
    Am J Obstet Gynecol; 2004 Oct 07; 191(4):1225-31. PubMed ID: 15507945
    [Abstract] [Full Text] [Related]

  • 10. Repeated medical abortions and the risk of preterm birth in the subsequent pregnancy.
    Liao H, Wei Q, Duan L, Ge J, Zhou Y, Zeng W.
    Arch Gynecol Obstet; 2011 Sep 07; 284(3):579-86. PubMed ID: 20978775
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate. A single agent for early abortion.
    Schaff EA, Penmetsa U, Eisinger SH, Franks P.
    J Reprod Med; 1997 Jan 07; 42(1):56-60. PubMed ID: 9018647
    [Abstract] [Full Text] [Related]

  • 12. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2004 Sep 07; 111(9):996-1000. PubMed ID: 15327616
    [Abstract] [Full Text] [Related]

  • 13. Obstetric outcomes after surgical abortion at > or = 20 weeks' gestation.
    Chasen ST, Kalish RB, Gupta M, Kaufman J, Chervenak FA.
    Am J Obstet Gynecol; 2005 Sep 07; 193(3 Pt 2):1161-4. PubMed ID: 16157130
    [Abstract] [Full Text] [Related]

  • 14. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R, Graziosi GC, Christiaens GC, Bruinse HW, Mol BW.
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep 10; 116(1):16-21. PubMed ID: 15294361
    [Abstract] [Full Text] [Related]

  • 15. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H, Ngoc NT, Schaff E, Coyaji K, Ambardekar S, Westheimer E, Winikoff B.
    Obstet Gynecol; 2007 Apr 10; 109(4):895-901. PubMed ID: 17400851
    [Abstract] [Full Text] [Related]

  • 16. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK, Mukherji J, Kamilya GS, Ray S, Hazra A.
    Acta Obstet Gynecol Scand; 2006 Apr 10; 85(12):1458-62. PubMed ID: 17260222
    [Abstract] [Full Text] [Related]

  • 17. Methods for induced abortion.
    Stubblefield PG, Carr-Ellis S, Borgatta L.
    Obstet Gynecol; 2004 Jul 10; 104(1):174-85. PubMed ID: 15229018
    [Abstract] [Full Text] [Related]

  • 18. Modelling prior reproductive history to improve prediction of risk for very preterm birth.
    Watson LF, Rayner JA, King J, Jolley D, Forster D, Lumley J.
    Paediatr Perinat Epidemiol; 2010 Sep 10; 24(5):402-15. PubMed ID: 20670221
    [Abstract] [Full Text] [Related]

  • 19. Induced abortion as a risk factor for subsequent fetal loss.
    Infante-Rivard C, Gauthier R.
    Epidemiology; 1996 Sep 10; 7(5):540-2. PubMed ID: 8862989
    [Abstract] [Full Text] [Related]

  • 20. Dilation and evacuation at >or=20 weeks: comparison of operative techniques.
    Chasen ST, Kalish RB, Gupta M, Kaufman JE, Rashbaum WK, Chervenak FA.
    Am J Obstet Gynecol; 2004 May 10; 190(5):1180-3. PubMed ID: 15167815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.